Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that its HIV vaccine, PENNVAX®-GP, produced amongst the highest overall levels of immune ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE